Knowstox

Fundamentals snapshot

Hyperfine, Inc.

HYPR · NGM · Healthcare · Medical Devices

Current price

$0.93

52-week range

$0.75 - $2.22

Market cap

$98.70M

One-glance verdict

Not enough data

Fair value unavailable

Not enough cash-flow history to value this one with our method.

Balance sheet

Healthy

-36.25x Concerning

Net cash $30.05M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Hyperfine, Inc.

Hyperfine, Inc. makes portable MRI machines that are smaller and less powerful than typical ones, helping doctors see inside patients' bodies for things like strokes or head injuries. They make money by selling these machines, offering support services, and providing a cloud system to store and view images (this is where most of their revenue comes from). This matters because it means they can reach more hospitals and clinics, especially in places that can't afford or fit larger MRI equipment.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-8.68M FY2024 Q4 $-8.37M FY2025 Q1 $-9.72M FY2025 Q2 $-8.43M FY2025 Q3 $-5.71M FY2025 Q4 $-5.27M FY2026 Q1 $-9.25M FY2026 Q2 $-7.30M
Revenue $3.90M
Net income $-9.30M
Diluted EPS -0.09
Operating cash flow $-7.27M
Free cash flow $-7.30M
Revenue $3.90M
Net income $-8.62M
Diluted EPS -0.09
Operating cash flow $-9.01M
Free cash flow $-9.25M
Revenue $5.29M
Net income $-5.91M
Diluted EPS -0.05
Operating cash flow $-5.21M
Free cash flow $-5.27M
Revenue $3.44M
Net income $-11.02M
Diluted EPS -0.14
Operating cash flow $-5.58M
Free cash flow $-5.71M
Revenue $2.70M
Net income $-9.22M
Diluted EPS -0.12
Operating cash flow $-7.91M
Free cash flow $-8.43M
Revenue $2.14M
Net income $-9.42M
Diluted EPS -0.12
Operating cash flow $-9.25M
Free cash flow $-9.72M
Revenue $2.32M
Net income $-10.39M
Diluted EPS -0.14
Operating cash flow $-8.36M
Free cash flow $-8.37M
Revenue $3.64M
Net income $-10.33M
Diluted EPS -0.14
Operating cash flow $-8.52M
Free cash flow $-8.68M

Is it cheap or expensive?

Fair value — vs current price $0.93

We couldn't calculate a fair value right now.

lower confidence

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Is it drowning in debt?

Healthy

Net cash $30.0M - more cash than debt. Interest coverage -36.3x.

Net debt $-30.05M
Interest coverage -36.25x

Hyperfine, Inc. is healthier than 0 of 1 peers on balance-sheet leverage.

Healthy
Worse cushion Baseline Better cushion
HYPR BASELINE Hyperfine, Inc.

Total debt $13.41M Interest coverage -36.25x This is the baseline the peer rows are being compared against.

What you should know

The case for and against HYPR

1 Reward 1 Risk

Rewards

  • Revenue grew 21.9% last year.

Risks

  • Return on equity was -97.0% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
-2.91x
P/B
2.68x
P/S
5.97x
EV/EBITDA
-2.11x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
51.4%
Operating margin
-216.9%
Net margin
-210.8%
ROE
-97.0%
ROA
-38.8%

Health

Liquidity and balance-sheet strength

Debt / equity
0.36x
Current ratio
6.15x
Quick ratio
5.11x
Total debt
$13.41M
Total cash
$43.46M

Growth

How the business has been compounding

Revenue TTM
$16.54M
Revenue 5Y CAGR
73.5%
EPS TTM
-0.37
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$-27.07M
Free CF TTM
$-29.13M
FCF margin
-176.2%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
—
Last ex-div date
—